Assenagon Asset Management S.A. Boosts Position in Theravance Biopharma, Inc. $TBPH
Assenagon Asset Management S.A. boosted its position in Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) by 1,629.4% during the 3rd quarter, according to its most recent Form 13F filing with...